Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001837918 | SCV000554794 | benign | Hypercholesterolemia, autosomal dominant, type B; Familial hypobetalipoproteinemia 1 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001172132 | SCV000720984 | likely benign | not provided | 2019-11-01 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000606455 | SCV000857803 | likely benign | not specified | 2017-11-17 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000771162 | SCV000903043 | likely benign | Familial hypercholesterolemia | 2018-01-05 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001172132 | SCV001335090 | likely benign | not provided | 2020-02-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002393179 | SCV002671944 | likely benign | Cardiovascular phenotype | 2017-09-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV001172132 | SCV004218910 | benign | not provided | 2023-07-26 | criteria provided, single submitter | clinical testing | |
GENin |
RCV000771162 | SCV005074075 | benign | Familial hypercholesterolemia | 2024-05-03 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004533208 | SCV004753167 | likely benign | APOB-related disorder | 2023-06-14 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |